Careers Ireland

Students' embarking on their career journey – Is Féidir linn

  • October 2012
    M T W T F S S
    « Sep   Nov »
    1234567
    891011121314
    15161718192021
    22232425262728
    293031  
  • Blog Stats

    • 223,622 hits
  • Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 685 other followers

Drugs firm to create 44 Dublin jobs

Posted by Francis O' Toole on October 4, 2012

Minister for Jobs, Enterprise and Innovation Richard Bruton announced plans for Aspen to set up a regulatory, quality assurance and supply projects centre of excellence in Citywest. Photograph: Julien Behal/PA WireMinister for Jobs, Enterprise and Innovation Richard Bruton announced plans for Aspen to set up a regulatory, quality assurance and supply projects centre of excellence in Citywest. Photograph: Julien Behal/PA Wire

Generic drugs company Aspen is to expand its Dublin operation with the creation of 44 jobs.

Minister for Jobs, Enterprise and Innovation Richard Bruton announced plans for Aspen to set up a regulatory, quality assurance and supply projects centre of excellence in Citywest.

“Pharmaceuticals is a major sector of strength for Ireland, with nine out of the top 10 global companies located here,” said Mr Bruton.

“However a key part of the Government’s plan for jobs and growth is targeting the areas of growth within what is a changing sector — in particular, generics.”

Aspen set up shop in Ireland in 2010, which has since become its European marketing and supply chain headquarters. The new jobs, supported by IDA Ireland, will bring the company’s total workforce in Ireland to 58.

The firm is the world’s largest producer of HIV drugs in South Africa.

Aspen group chief executive Stephen Saad said Ireland has a workforce with the specialised skills the company requires.

He said it also boasts a strong regulatory and business environment. “I am delighted to see the continued growth of Aspen here in Ireland,” he added.

Meanwhile, IDA chief executive Barry O’Leary said Aspen’s decision to expand in Ireland adds to the country’s cluster of life sciences operations.

He said a key member of that cluster is GlaxoSmithKline, which owns a 20 per cent share in Aspen here.

“Ireland offers South Africa’s largest pharmaceutical company a strategic location from which to support its ongoing expansion and grow its sales across Europe,” said Mr O’Leary.

“I wish Aspen every success with this expansion and look forward to continue to work closely with the company as it further embeds its operations here.”

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s